Liposome preparation containing Oxaliplatin

A technology of liposome preparation and oxaliplatin, which is applied in the directions of liposome delivery, active ingredients of heavy metal compounds, drug combination, etc., can solve problems such as stability of liposome preparations

Inactive Publication Date: 2005-06-22
MEBIOPHARM
View PDF3 Cites 16 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, many compounds cannot be effectively encapsulated in liposo...

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Liposome preparation containing Oxaliplatin
  • Liposome preparation containing Oxaliplatin
  • Liposome preparation containing Oxaliplatin

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0036] The preparation of embodiment 1 liposome

[0037] This example provides a general strategy for preparing liposome compositions of the invention. Of course, other strategies that can be obtained by those skilled in the art by referring to this disclosed strategy can also be used. This example describes the use of reverse phase evaporation (REV) to prepare an embodiment of the liposomal formulations of the present invention (see, eg, US Patent No. 4,235,871 for a more detailed description).

[0038] In order to stably store the hydrophilic polymer in the lipid bilayer, the phospholipid derivative of the hydrophilic polymer can be prepared first, and then the phospholipid derivative, phospholipid and lipid can be used to prepare liposomes. Hydrophilic polymers are synthesized as derivatives in which phospholipid moieties are chemically attached to the polymer. The phospholipid portion of the derivative thus serves to stably hold the derivative in the lipid bilayer. Phos...

Embodiment 2

[0044] Example 2 Liposome Preparation

[0045] In this alternative mode of preparing liposomes, the lipid film forming step is carried out in a vessel partially filled with an inert solid contact material. Important changes can be in size, volume distribution, shape and composition of the exposed material. The primary characteristics of a contact substance are: (1) The contact substance is inert to the materials used in the formulation, in other words, there are no undesired gaps between the contact substance and the lipids, lipophilic substances, organic solvents or aqueous liquids used reaction, and (2) the contact substance has been solid during the reaction step, in other words, the contact substance should not dissolve or fragment, but should provide an appropriate solid surface to support the liquid phase film. Previous pilot tests using glass beads or glass spheres as the inert solid contact substance have proven that these materials are particularly suitable. It is a...

Embodiment 3

[0052] Example 3 Cytotoxicity of Oxaliplatin

[0053] An oxaliplatin solution was prepared by dissolving oxaliplatin in a 9% sucrose solution at a concentration of 8 mg oxaliplatin / ml solution.

[0054] AsPC-1 cells were cultured at 37°C in 5% CO in RPMI 11640 medium supplemented with 10% fetal bovine serum with various concentrations of oxaliplatin solutions. 2 Incubate for 4 hours. The medium was changed and the cells were cultured for an additional 48 hours. Assay cell viability with commercially available cytotoxicity assay kits, e.g., APO-ALERT TM Assay kit (Clontech, BD, Biosciences, Clontech, Palo. Alto, CA). Add culture medium to the cells and in 5% CO 2 Incubate for 2 hours, and measure the color development at 450nm (reference wavelength: 620nm). The result is shown in Figure 2. LD of oxaliplatin 50 >8ug / ml.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
Diameteraaaaaaaaaa
Login to view more

Abstract

The invention discloses a liposome preparation containing antineoplastic metallic complex which is derived by hydrophilic polymers and aglycones, in one embodiment, the antineoplastic metallic complex includes Oxaliplatin, the hydrophilic polymers include polyethylene glycol, the aglycone is transferrin. In accordance with the invention, the transferring expressed on the surface of the tumor cell can facilitate the absorption of agent in the liposome by the tumor cells. The invention also provides the pharmaceutical composition containing the liposome and method for application.

Description

field of invention [0001] The present invention relates to a liposome preparation used as an antineoplastic drug. Background technique [0002] The background of the present invention described below is only provided for the reader to understand the present invention without describing in detail or combining the prior art of the present invention. [0003] Cisplatin is an antineoplastic drug that has been widely used to treat a variety of cancers, including testicular tumors, bladder tumors, pelvic tumors, ureteromas, prostate cancer, ovarian cancer, head and neck cancer, non-small cell Lung cancer, esophageal cancer, cervical cancer, neuroblastoma and stomach cancer. However, cisplatin has great disadvantages because it is highly toxic and is often accompanied by adverse side effects such as renal dysfunction including acute renal failure, suppression of bone marrow function, nausea, vomiting, and loss of appetite. To overcome these disadvantages,...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K9/127A61K31/282A61P35/00
Inventor 江里口正纯柳卫宏宣丸山一雄藤泽忠司
Owner MEBIOPHARM
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap